Alex Chan

@alex8chan.bsky.social

Econ prof @Harvard.edu HBS; @nber.org; PhD @Stanford.edu; ex-Fortune 5 Healthcare SVP; ex-@McKinsey; 🐈‍⬛, 🍀 and 🚂 enthusiast

Insanely grateful to anyone who takes the time to read my papers. That’s real effort, and I never take it for granted. When you email/comment with thoughts or send work that connects my thinking to the wider scholarly discourse? Pure joy. Best job ever. Thanks thanks thank 🙏 ❤️❤️

💬 Viewpoint: The CMS IOTA model incentivizes increased kidney transplants by rewarding volume, organ acceptance, and short-term graft survival, but risks remain for equitable access and long-term patient outcomes among those with end-stage kidney disease. ja.ma/4s8ZLTE

JAMA viewpoint article "Reimagining Transplant Center Incentives Beyond the CMS IOTA Model" by Alex Chan, MPH, PhD; Alvin E. Roth, PhD. Includes table outlining a holistic performance model for kidney transplants, listing desired outcomes.